Advances in Adrenal and Extra-adrenal Paraganglioma: Practical Synopsis for Pathologists
- 23 September 2022
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Advances in Anatomic Pathology
- Vol. 30 (1), 47-57
- https://doi.org/10.1097/pap.0000000000000365
Abstract
Adrenal paraganglioma (or “pheochromocytoma”) and extra-adrenal paraganglioma, collectively abbreviated PPGL, are rare but spectacular nonepithelial neuroendocrine neoplasms. These are the most inheritable neoplasia of all, with a metastatic potential in a varying degree. As of such, these lesions demand careful histologic, immunohistochemical, and genetic characterization to provide the clinical team with a detailed report taking into account the anticipated prognosis and risk of syndromic/inherited disease. While no histologic algorithm, immunohistochemical biomarker, or molecular aberration single-handedly can identify potentially lethal cases upfront, the combined analysis of various risk parameters may stratify PPGL patients more stringently than previously. Moreover, the novel 2022 WHO Classification of Endocrine and Neuroendocrine Tumors also brings some new concepts into play, not least the reclassification of special neuroendocrine neoplasms (cauda equina neuroendocrine tumor and composite gangliocytoma/neuroma-neuroendocrine tumor) previously thought to belong to the spectrum of PPGL. This review focuses on updated key diagnostic and prognostic concepts that will aid when facing this rather enigmatic tumor entity in clinical practice.Keywords
This publication has 99 references indexed in Scilit:
- Pigmented paraganglioma of the kidney: a case reportDiagnostic Pathology, 2012
- Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressorsGenes & Development, 2012
- Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paragangliomaHuman Molecular Genetics, 2011
- SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signallingEndocrine-Related Cancer, 2010
- Extended Ischemia Prevents HIF1α Degradation at Reoxygenation by Impairing Prolyl-hydroxylationOnline Journal of Public Health Informatics, 2010
- Germline mutations in TMEM127 confer susceptibility to pheochromocytomaNature Genetics, 2010
- The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressorGenes & Development, 2008
- Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant NeoplasmsThe American Journal of Surgical Pathology, 2002
- Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosisGenes, Chromosomes and Cancer, 1992
- Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinomaNature, 1988